Across the UK, 1 in 5 adults have hearing loss and around 1 in 8 adults live with tinnitus. Despite this, there are not yet any clinically approved treatments or cures. We are determined to change this.
We support translational research – where promising discoveries move from the laboratory into clinical trials. RNID’s translational activity to accelerate the development of safe and effective treatments has four key components:
- working with partners
- engaging with patients.
Find out more about how we can help in each of these areas below. You can also email firstname.lastname@example.org for more information.
We fund applied research projects based at research institutes and small-medium enterprises (SMEs) across the world.
Hearing Therapeutics Initiative
The Initiative accelerates the development of therapeutics to prevent and treat hearing loss and tinnitus, by offering support to academic and commercial organisations.
Engaging patients in research
Find out how we can bring about and promote the engagement of patients in research.
We provide expert advice to pharmaceutical, biotechnology and medical-device companies on opportunities in the hearing loss and tinnitus therapy areas.